Royalty Pharma Manager specializes in investment management for its client, which holds royalty interests in pharmaceutical, biopharmaceutical, medical, and healthcare products. The firm advises on investments in royalty interests in marketed and development-stage products. Royalty Pharma Manager tailors its advisory services to the individual needs and investment mandates of its client, adhering to the investment strategy set forth in the client's prospectuses and investment management agreements.
Fee Structure
Royalty Pharma Manager receives compensation from its client in the form of an operating and personnel expense fee, which is either a flat fee or determined on a cost-plus basis. The firm and an entity controlled by its CEO also receive performance-based compensation. The fees are not negotiable.